论文部分内容阅读
据 Am J Respir Crit Care Med(1996;153:1790)载荷兰的研究人员 Diamant 等医师称,吸入肝素是有效的抗哮喘疗法。他们证明,吸入肝素可减少抗哮喘疗法;减少哮喘男病人在吸入变应原后的晚发哮喘反应。肝素给药未见不良反应。同安慰剂组比,肝素吸入使早期哮喘反应平均下降40%,使晚发哮喘反应平均下降36%,但仅在晚发哮喘反应的组间差异具有显著性。摘自《中国医学论坛报》1996年12月19日7版。
According to Am J Respir Crit Care Med (1996; 153: 1790) Dutch researchers Diamant and other physicians said that inhaled heparin is an effective anti-asthma therapy. They show that inhaled heparin can reduce anti-asthma therapy and reduce late-onset asthma in asthmatic men after inhalation of the allergen. Heparin administration without adverse reactions. Compared with placebo, heparin inhalation reduced the average early asthmatic response by 40% and the late asthmatic response by 36% on average, but only between late-onset asthmatic responses was significant. From “China Medical Tribune” December 19, 1996 7 edition.